Abstract
The consequences of injuries to the CNS are profound and persistent, resulting in substantial burden to both the individual patient and society. Existing treatments for CNS injuries such as stroke, traumatic brain injury and spinal cord injury have proved inadequate, partly owing to an incomplete understanding of post-injury cellular and molecular changes. MicroRNAs (miRNAs) are RNA molecules composed of 20–24 nucleotides that function to inhibit mRNA translation and have key roles in normal CNS development and function, as well as in disease. However, a role for miRNAs as effectors of CNS injury has recently emerged. Use of bioinformatics to assess the mRNA targets of miRNAs enables high-order analysis of interconnected networks, and can reveal affected pathways that may not be identifiable with the use of traditional techniques such as gene knock-in or knockout approaches, or mRNA microarrays. In this Review, we discuss the findings of miRNA microarray studies of spinal cord injury, traumatic brain injury and stroke, as well as the use of gene ontological algorithms to discern global patterns of molecular and cellular changes following such injuries. Furthermore, we examine the current state of miRNA-based therapies and their potential to improve functional outcomes in patients with CNS injuries.
Key Points
-
MicroRNAs (miRNAs) are critical for normal development but also have a role in disease, particularly of the CNS
-
miRNA microarrays provide the highest-order view of changes that occur following injuries to the CNS, such as stroke, spinal cord injury or traumatic brain injury
-
These CNS injuries affect key cellular pathways such as apoptosis, inflammation and cellular proliferation, all of which are regulated by miRNAs
-
miRNA-based therapies that augment or inhibit miRNA activity, and with enhanced bioavailability and function, are currently being developed
-
Artificial miRNAs can be designed to bind to and modify groups of mRNA transcripts that are not naturally targeted by endogenous miRNAs
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Coronado, V. G. et al. Surveillance for traumatic brain injury-related deaths—United States, 1997–2007. MMWR Surveill. Summ. 60, 1–32 (2011).
Paralysis facts & figures. Christopher & Dana Reeve Foundation Paralysis Resource Center [online], (2012).
Stroke 101 fact sheet. National Stroke Association [online], (2012).
Munro, K. M. & Perreau, V. M. Current and future applications of transcriptomics for discovery in CNS disease and injury. Neurosignals 17, 311–327 (2009).
Qureshi, I. A. & Mehler, M. F. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat. Rev. Neurosci. 13, 528–541 (2012).
Salta, E. & De Strooper, B. Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol. 11, 189–200 (2012).
Carthew, R. W. & Sontheimer, E. J. Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642–655 (2009).
Bian, S. & Sun, T. Functions of noncoding RNAs in neural development and neurological diseases. Mol. Neurobiol. 44, 359–373 (2011).
Meza-Sosa, K. F., Valle-García, D., Pedraza-Alva, G. & Pérez-Martínez, L. Role of microRNAs in central nervous system development and pathology. J. Neurosci. Res. 90, 1–12 (2012).
Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).
Lee, Y., Jeon, K., Lee, J. T., Kim, S. & Kim, V. N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663–4670 (2002).
Zeng, Y. & Cullen, B. R. Sequence requirements for micro RNA processing and function in human cells. RNA 9, 112–123 (2003).
Basyuk, E., Suavet, F., Doglio, A., Bordonné, R. & Bertrand, E. Human let-7 stem-loop precursors harbor features of RNase III cleavage products. Nucleic Acids Res. 31, 6593–6597 (2003).
Han, J. et al. The Drosha–DGCR8 complex in primary microRNA processing. Genes Dev. 18, 3016–3027 (2004).
Lau, N. C., Lim, L. P., Weinstein, E. G. & Bartel, D. P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294, 858–862 (2001).
Hutvágner, G. et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834–838 (2001).
Chendrimada, T. P. et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436, 740–744 (2005).
Long, J. M. & Lahiri, D. K. Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders. Exp. Neurol. 235, 402–418 (2012).
Nass, D. et al. miR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. 19, 375–383 (2009).
Hammond, S. M., Bernstein, E., Beach, D. & Hannon, G. J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404, 293–296 (2000).
Martinez, J., Patkaniowska, A., Urlaub, H., Lührmann, R. & Tuschl, T. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110, 563–574 (2002).
Peters, L. & Meister, G. Argonaute proteins: mediators of RNA silencing. Mol. Cell 26, 611–623 (2007).
Fabian, M. R. & Sonenberg, N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol. 19, 586–593 (2012).
Selbach, M. et al. Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58–63 (2008).
Baek, D. et al. The impact of microRNAs on protein output. Nature 455, 64–71 (2008).
Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835–840 (2010).
Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. & Burge, C. B. Prediction of mammalian microRNA targets. Cell 115, 787–798 (2003).
Esquela-Kerscher, A. & Slack, F. J. Oncomirs—microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259–269 (2006).
Stark, A., Brennecke, J., Bushati, N., Russell, R. B. & Cohen, S. M. Animal microRNAs confer robustness to gene expression and have a significant impact on 3′UTR evolution. Cell 123, 1133–1146 (2005).
Sandberg, R., Neilson, J. R., Sarma, A., Sharp, P. A. & Burge, C. B. Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science 320, 1643–1647 (2008).
Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science 294, 853–858 (2001).
Lagos-Quintana, M., Rauhut, R., Meyer, J., Borkhardt, A. & Tuschl, T. New microRNAs from mouse and human. RNA 9, 175–179 (2003).
Lagos-Quintana, M. et al. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735–739 (2002).
Lee, R. C. & Ambros, V. An extensive class of small RNAs in Caenorhabditis elegans. Science 294, 862–864 (2001).
Bernstein, E. et al. Dicer is essential for mouse development. Nat. Genet. 35, 215–217 (2003).
De Pietri Tonelli, D. et al. miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex. Development 135, 3911–3921 (2008).
Davis, T. H. et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 28, 4322–4330 (2008).
Liu, J. et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305, 1437–1441 (2004).
Bak, M. et al. MicroRNA expression in the adult mouse central nervous system. RNA 14, 432–444 (2008).
Miska, E. A. et al. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 5, R68 (2004).
Smith, B. et al. Large-scale expression analysis reveals distinct microRNA profiles at different stages of human neurodevelopment. PLoS ONE 5, e11109 (2010).
Landgraf, P. et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401–1414 (2007).
Zheng, K., Li, H., Zhu, Y., Zhu, Q. & Qiu, M. MicroRNAs are essential for the developmental switch from neurogenesis to gliogenesis in the developing spinal cord. J. Neurosci. 30, 8245–8250 (2010).
Li, Y., Wang, F., Lee, J. A. & Gao, F. B. MicroRNA-9a ensures the precise specification of sensory organ precursors in Drosophila. Genes Dev. 20, 2793–2805 (2006).
Zhao, C., Sun, G., Li, S. & Shi, Y. A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat. Struct. Mol. Biol. 16, 365–371 (2009).
Cheng, L. C., Pastrana, E., Tavazoie, M. & Doetsch, F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 12, 399–408 (2009).
Liu, X. S. et al. MicroRNA profiling in subventricular zone after stroke: miR-124a regulates proliferation of neural progenitor cells through Notch signaling pathway. PLoS ONE 6, e23461 (2011).
He, X., Yu, Y., Awatramani, R. & Lu, Q. R. Unwrapping myelination by microRNAs. Neuroscientist 18, 45–55 (2012).
Dugas, J. C. et al. Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65, 597–611 (2010).
Zhao, X. et al. MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 65, 612–626 (2010).
Budde, H. et al. Control of oligodendroglial cell number by the miR-17-92 cluster. Development 137, 2127–2132 (2010).
Smirnova, L. et al. Regulation of miRNA expression during neural cell specification. Eur. J. Neurosci. 21, 1469–1477 (2005).
Sahni, V. et al. BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury. J. Neurosci. 30, 1839–1855 (2010).
Zheng, K., Li, H., Huang, H. & Qiu, M. MicroRNAs and glial cell development. Neuroscientist 18, 114–118 (2012).
Tao, J. et al. Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J. Neurosci. 31, 8306–8319 (2011).
Ackery, A., Tator, C. & Krassioukov, A. A global perspective on spinal cord injury epidemiology. J. Neurotrauma 21, 1355–1370 (2004).
Spinal cord injury facts and figures at a glance. National Spinal Cord Injury Statistical Center [online], (2012).
Liu, N. K., Wang, X. F., Lu, Q. B. & Xu, X. M. Altered microRNA expression following traumatic spinal cord injury. Exp. Neurol. 219, 424–429 (2009).
Yunta, M. et al. MicroRNA dysregulation in the spinal cord following traumatic injury. PLoS ONE 7, e34534 (2012).
De Biase, A. et al. Gene expression profiling of experimental traumatic spinal cord injury as a function of distance from impact site and injury severity. Physiol. Genomics 22, 368–381 (2005).
Strickland, E. R. et al. MicroRNA dysregulation following spinal cord contusion: implications for neural plasticity and repair. Neuroscience 186, 146–160 (2011).
Wu, J. et al. miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle 9, 1809–1818 (2010).
Jee, M. K., Jung, J. S., Im, Y. B., Jung, S. J. & Kang, S. K. Silencing of miR20a is crucial for Ngn1-mediated neuroprotection in injured spinal cord. Hum. Gene Ther. 23, 508–520 (2012).
Bertrand, N., Castro, D. S. & Guillemot, F. Proneural genes and the specification of neural cell types. Nat. Rev. Neurosci. 3, 517–530 (2002).
Carraro, G. et al. miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-Cadherin distribution. Dev. Biol. 333, 238–250 (2009).
Yan, H. et al. MicroRNA-20a overexpression inhibited proliferation and metastasis of pancreatic carcinoma cells. Hum. Gene Ther. 21, 1723–1734 (2010).
Jee, M. K. et al. MicroRNA 486 is a potentially novel target for the treatment of spinal cord injury. Brain 135, 1237–1252 (2012).
Uittenbogaard, M., Baxter, K. K. & Chiaramello, A. The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass. ASN Neuro 2, e00034 (2010).
Liu, G., Detloff, M. R., Miller, K. N., Santi, L. & Houlé, J. D. Exercise modulates microRNAs that affect the PTEN/mTOR pathway in rats after spinal cord injury. Exp. Neurol. 233, 447–456 (2012).
Bhalala, O. G. et al. microRNA-21 regulates astrocytic response following spinal cord injury. J. Neurosci. 32, 17935–17947 (2012).
Chan, J. A., Krichevsky, A. M. & Kosik, K. S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65, 6029–6033 (2005).
Ciafrè, S. A. et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 334, 1351–1358 (2005).
Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA 103, 2257–2261 (2006).
van Rooij, E. et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl Acad. Sci. USA 103, 18255–18260 (2006).
Fawcett, J. W. & Asher, R. A. The glial scar and central nervous system repair. Brain Res. Bull. 49, 377–391 (1999).
Barnabé-Heider, F. & Frisén, J. Stem cells for spinal cord repair. Cell Stem Cell 3, 16–24 (2008).
Sofroniew, M. V. Reactive astrocytes in neural repair and protection. Neuroscientist 11, 400–407 (2005).
Davis, B. N., Hilyard, A. C., Lagna, G. & Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56–61 (2008).
van den Brand, R. et al. Restoring voluntary control of locomotion after paralyzing spinal cord injury. Science 336, 1182–1185 (2012).
Liu, G., Keeler, B. E., Zhukareva, V. & Houlé, J. D. Cycling exercise affects the expression of apoptosis-associated microRNAs after spinal cord injury in rats. Exp. Neurol. 226, 200–206 (2010).
Liu, K. et al. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 13, 1075–1081 (2010).
Shively, S. B. & Perl, D. P. Traumatic brain injury, shell shock, and posttraumatic stress disorder in the military—past, present, and future. J. Head Trauma Rehabil. 27, 234–239 (2012).
Lei, P., Li, Y., Chen, X., Yang, S. & Zhang, J. Microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury. Brain Res. 1284, 191–201 (2009).
Orrison, W. W. et al. Traumatic brain injury: a review and high-field MRI findings in 100 unarmed combatants using a literature-based checklist approach. J. Neurotrauma 26, 689–701 (2009).
Cohen, A. S. et al. Injury-induced alterations in CNS electrophysiology. Prog. Brain Res. 161, 143–169 (2007).
Redell, J. B., Liu, Y. & Dash, P. K. Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes. J. Neurosci. Res. 87, 1435–1448 (2009).
Hu, Z. et al. Expression of miRNAs and their cooperative regulation of the pathophysiology in traumatic brain injury. PLoS ONE 7, e39357 (2012).
Redell, J. B., Zhao, J. & Dash, P. K. Altered expression of miRNA-21 and its targets in the hippocampus after traumatic brain injury. J. Neurosci. Res. 89, 212–221 (2011).
Balakathiresan, N. et al. MicroRNA let-7i is a promising serum biomarker for blast-induced traumatic brain injury. J. Neurotrauma 29, 1379–1387 (2012).
Geyer, C., Ulrich, A., Gräfe, G., Stach, B. & Till, H. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury. J. Neurosurg. Pediatr. 4, 339–344 (2009).
Papa, L. et al. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit. Care Med. 38, 138–144 (2010).
Svetlov, S. I. et al. Morphologic and biochemical characterization of brain injury in a model of controlled blast overpressure exposure. J. Trauma 69, 795–804 (2010).
Redell, J. B., Moore, A. N., Ward, N. H. 3rd, Hergenroeder, G. W. & Dash, P. K. Human traumatic brain injury alters plasma microRNA levels. J. Neurotrauma 27, 2147–2156 (2010).
Marion, D. & Bullock, M. R. Current and future role of therapeutic hypothermia. J. Neurotrauma 26, 455–467 (2009).
Dietrich, W. D., Atkins, C. M. & Bramlett, H. M. Protection in animal models of brain and spinal cord injury with mild to moderate hypothermia. J. Neurotrauma 26, 301–312 (2009).
Choi, H. A., Badjatia, N. & Mayer, S. A. Hypothermia for acute brain injury—mechanisms and practical aspects. Nat. Rev. Neurol. 8, 214–222 (2012).
Truettner, J. S., Alonso, O. F., Bramlett, H. M. & Dietrich, W. D. Therapeutic hypothermia alters microRNA responses to traumatic brain injury in rats. J. Cereb. Blood Flow Metab. 31, 1897–1907 (2011).
Bushnell, C. D. Stroke and the female brain. Nat. Clin. Pract. Neurol. 4, 22–33 (2008).
Tan, K. S. et al. Expression profile of MicroRNAs in young stroke patients. PLoS ONE 4, e7689 (2009).
Liu, D. Z. et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab. 30, 92–101 (2010).
Badaut, J., Lasbennes, F., Magistretti, P. J. & Regli, L. Aquaporins in brain: distribution, physiology, and pathophysiology. J. Cereb. Blood Flow Metab. 22, 367–378 (2002).
Manley, G. T. et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat. Med. 6, 159–163 (2000).
Papadopoulos, M. C., Manley, G. T., Krishna, S. & Verkman, A. S. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J. 18, 1291–1293 (2004).
Jeyaseelan, K., Lim, K. Y. & Armugam, A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 39, 959–966 (2008).
Sepramaniam, S. et al. MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia. J. Biol. Chem. 285, 29223–29230 (2010).
Yin, K. J. et al. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol. Dis. 38, 17–26 (2010).
Shi, G. et al. Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury. Exp. Brain Res. 216, 225–230 (2012).
Buller, B. et al. MicroRNA-21 protects neurons from ischemic death. FEBS J. 277, 4299–4307 (2010).
Raha, S. & Robinson, B. H. Mitochondria, oxygen free radicals, and apoptosis. Am. J. Med. Genet. 106, 62–70 (2001).
Dharap, A., Bowen, K., Place, R., Li, L. C. & Vemuganti, R. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J. Cereb. Blood Flow Metab. 29, 675–687 (2009).
Eltzschig, H. K. & Eckle, T. Ischemia and reperfusion—from mechanism to translation. Nat. Med. 17, 1391–1401 (2011).
Dharap, A. & Vemuganti, R. Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J. Neurochem. 113, 1685–1691 (2010).
Lee, S. T. et al. MicroRNAs induced during ischemic preconditioning. Stroke 41, 1646–1651 (2010).
Lusardi, T. A. et al. Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J. Cereb. Blood Flow Metab. 30, 744–756 (2010).
Stenzel-Poore, M. P. et al. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 362, 1028–1037 (2003).
Ziu, M., Fletcher, L., Rana, S., Jimenez, D. F. & Digicaylioglu, M. Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury. PLoS ONE 6, e14724 (2011).
Shih, J. D., Waks, Z., Kedersha, N. & Silver, P. A. Visualization of single mRNAs reveals temporal association of proteins with microRNA-regulated mRNA. Nucleic Acids Res. 39, 7740–7749 (2011).
Judge, A. D. et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23, 457–462 (2005).
Peacock, H. et al. Nucleobase and ribose modifications control immunostimulation by a microRNA-122-mimetic RNA. J. Am. Chem. Soc. 133, 9200–9203 (2011).
Akao, Y. et al. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther. 17, 398–408 (2010).
Pereira, D. M., Rodrigues, P. M., Borralho, P. M. & Rodrigues, C. M. Delivering the promise of miRNA cancer therapeutics. Drug Discov. Today 18, 282–289 (2012).
Ouyang, Y. B. et al. miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol. Dis. 45, 555–563 (2012).
Lee, S. T. et al. Altered microRNA regulation in Huntington's disease models. Exp. Neurol. 227, 172–179 (2011).
Krützfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685–689 (2005).
Krützfeldt, J. et al. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 35, 2885–2892 (2007).
Broderick, J. A. & Zamore, P. D. MicroRNA therapeutics. Gene Ther. 18, 1104–1110 (2011).
Grünweller, A. & Hartmann, R. K. Locked nucleic acid oligonucleotides: the next generation of antisense agents? BioDrugs 21, 235–243 (2007).
Stenvang, J., Silahtaroglu, A. N., Lindow, M., Elmen, J. & Kauppinen, S. The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Semin. Cancer Biol. 18, 89–102 (2008).
Elmen, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896–899 (2008).
Elmen, J. et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 36, 1153–1162 (2008).
Lanford, R. E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198–201 (2010).
US National Library of Medicine. ClinicalTrials.gov[online], (2012).
Elmen, J. et al. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res. 33, 439–447 (2005).
Wang, H. et al. Synthetic microRNA cassette dosing: pharmacokinetics, tissue distribution and bioactivity. Mol. Pharm. 9, 1638–1644 (2012).
Ebert, M. S., Neilson, J. R. & Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721–726 (2007).
Luikart, B. W. et al. miR-132 mediates the integration of newborn neurons into the adult dentate gyrus. PLoS ONE 6, e19077 (2011).
Gentner, B. et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat. Methods 6, 63–66 (2009).
Schorey, J. S. & Bhatnagar, S. Exosome function: from tumor immunology to pathogen biology. Traffic 9, 871–881 (2008).
Simpson, R. J., Jensen, S. S. & Lim, J. W. Proteomic profiling of exosomes: current perspectives. Proteomics 8, 4083–4099 (2008).
Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341–345 (2011).
Kotipatruni, R. R. et al. p53- and Bax-mediated apoptosis in injured rat spinal cord. Neurochem. Res. 36, 2063–2074 (2011).
Nagel, S. et al. Microarray analysis of the global gene expression profile following hypothermia and transient focal cerebral ischemia. Neuroscience 208, 109–122 (2012).
Zeng, Y., Wagner, E. J. & Cullen, B. R. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell 9, 1327–1333 (2002).
De Guire, V. et al. Designing small multiple-target artificial RNAs. Nucleic Acids Res. 38, e140 (2010).
Acknowledgements
O. G. Bhalala and J. A. Kessler are supported by NIH Grants R01NS20013 and R01NS20778. M. Srikanth is supported by NIH Grant F30NS065590.
Author information
Authors and Affiliations
Contributions
O. G. Bhalala researched data for the article. All authors provided substantial contributions to discussion of content, writing the article, and to the review and/or editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Bhalala, O., Srikanth, M. & Kessler, J. The emerging roles of microRNAs in CNS injuries. Nat Rev Neurol 9, 328–339 (2013). https://doi.org/10.1038/nrneurol.2013.67
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2013.67
This article is cited by
-
Spinal cord injury: a study protocol for a systematic review and meta-analysis of microRNA alterations
Systematic Reviews (2022)
-
Long Non-coding RNAs (lncRNAs), A New Target in Stroke
Cellular and Molecular Neurobiology (2022)
-
MiR-182 Inhibition Protects Against Experimental Stroke in vivo and Mitigates Astrocyte Injury and Inflammation in vitro via Modulation of Cortactin Activity
Neurochemical Research (2022)
-
miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases
Cellular and Molecular Neurobiology (2022)
-
Regulation of the Glycine Transporter GLYT1 by microRNAs
Neurochemical Research (2022)